Analyst Upgrades Automatic Data Processing to Equal Weight Sets 214 Price Target
Bhatia Communications Shares Rise 3 on Strong Q4 FY26 Earnings Dividend Announcement Amid Market Selloff
Solar Panel Sales Rise as Businesses and Consumers Seek Cost Savings
Gen Z Bargain Hunters Drive Gains for Discount Retailers Walmart and Ross
Post Office Horizon Inquiry Faces FiveYear Delay Without 193m Funding Boost Police Chief Warns
OpenAI Reportedly Plans Confidential IPO Filing Aiming to Lead AI Race
CLDI Q4 2025 Earnings Significant EPS Beat Amid Ongoing Clinical Development
NiSource NI Q1 2026 Earnings EPS Falls Short But Stock Gains on Operational Resilience
US Energy Corp USEG Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally
KNSL Q1 2026 Earnings EPS Surges Past Estimates on Strong Underwriting Performance
ABCB Q1 2026 Earnings EPS Beats Estimates Stock Slides Slightly
NCLH Q1 2026 Earnings EPS Beat by 583 Drives Strong Stock Surge
PetMed Express PETS Faces Continued Pressure Amid 36 Decline Testing Key Support Levels
OReilly Automotive ORLY Edges Lower Amid Consolidation Near Key Support
Gesher Acquisition Corp II Warrants GSHRW Rallies 949 as Price Approaches Resistance at 025
NHPAP Preferred Stock Maintains Stability with Modest Uptick
Canterbury Park CPHC Holds Steady Near Resistance After Modest Gain
Middle East Conflict Challenges Gulf Regions AI Hub Ambitions
PPTA Q1 2026 Earnings Widening Losses Amid StantecFinanced Stibnite Gold Project Progress
Mount Logan Capital 800 Notes Due 2031 MLCIL Hold Steady Near 23 as Trading Volume Remains Muted
Grupo Cibest CIB Q4 2025 Earnings Massive EPS Miss Triggers Unexpected Stock Rally
BTDR Q1 2026 Earnings EPS Miss Exceeds 73 as Mining Headwinds Persist
NRG Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Edges Higher
UL Solutions Inc ULS Q1 2026 Earnings Strong Profit Beat Amid Solid Operational Execution
UNF Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower
BWEN Q1 2026 Earnings NarrowerThanExpected Loss Drives DoubleDigit Stock Rally
Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones